Trichosporon asahii Urinary Tract Infection in a Patient with Severe COVID-19
Trichosporon asahii is a yeast-like basidiomycete that is an emerging opportunistic infection in immunocompromised patients. Urinary tract infections due to T. asahii are rarely reported in the literature and typically seen only in immunocompromised patients. In addition to being immunocompromised,...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2021/6841393 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558829142802432 |
|---|---|
| author | Verschoyle Cronyn John Howard Leslie Chiang Lisa Le Zandraetta Tims-Cook Alida M Gertz |
| author_facet | Verschoyle Cronyn John Howard Leslie Chiang Lisa Le Zandraetta Tims-Cook Alida M Gertz |
| author_sort | Verschoyle Cronyn |
| collection | DOAJ |
| description | Trichosporon asahii is a yeast-like basidiomycete that is an emerging opportunistic infection in immunocompromised patients. Urinary tract infections due to T. asahii are rarely reported in the literature and typically seen only in immunocompromised patients. In addition to being immunocompromised, critically ill COVID-19 patients often have prolonged exposure to antibiotics, corticosteroids, and Foley catheters, which further increases their susceptibility to infection with T. asahii. There are limited case reports documenting successful treatment of T. asahii among hospitalized patients, particularly among COVID-19 patients, in the literature. Therefore, it is important that successful treatment regimens be reported. Here, we report a case of T. asahii urinary tract infection successfully treated with fluconazole and voriconazole in a 73-year-old male recovering from COVID-19. Urinary tract infections with T. asahii should be considered in persistently febrile COVID-19 patients with fungal urinary tract infections since prompt recognition and treatment can reduce the risk of disseminated disease and early mortality. |
| format | Article |
| id | doaj-art-d4caefe68e7242eb857c07d727ee52d8 |
| institution | Kabale University |
| issn | 2090-6633 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Infectious Diseases |
| spelling | doaj-art-d4caefe68e7242eb857c07d727ee52d82025-02-03T01:31:34ZengWileyCase Reports in Infectious Diseases2090-66332021-01-01202110.1155/2021/6841393Trichosporon asahii Urinary Tract Infection in a Patient with Severe COVID-19Verschoyle Cronyn0John Howard1Leslie Chiang2Lisa Le3Zandraetta Tims-Cook4Alida M Gertz5Wellstar Atlanta Medical Center Family Med Residency ProgramMedical College of GeorgiaWellstar Atlanta Medical Center Family Med Residency ProgramWellstar Atlanta Medical Center Family Med Residency ProgramWellstar Atlanta Medical Center Family Med Residency ProgramWellstar Atlanta Medical Center Family Med Residency ProgramTrichosporon asahii is a yeast-like basidiomycete that is an emerging opportunistic infection in immunocompromised patients. Urinary tract infections due to T. asahii are rarely reported in the literature and typically seen only in immunocompromised patients. In addition to being immunocompromised, critically ill COVID-19 patients often have prolonged exposure to antibiotics, corticosteroids, and Foley catheters, which further increases their susceptibility to infection with T. asahii. There are limited case reports documenting successful treatment of T. asahii among hospitalized patients, particularly among COVID-19 patients, in the literature. Therefore, it is important that successful treatment regimens be reported. Here, we report a case of T. asahii urinary tract infection successfully treated with fluconazole and voriconazole in a 73-year-old male recovering from COVID-19. Urinary tract infections with T. asahii should be considered in persistently febrile COVID-19 patients with fungal urinary tract infections since prompt recognition and treatment can reduce the risk of disseminated disease and early mortality.http://dx.doi.org/10.1155/2021/6841393 |
| spellingShingle | Verschoyle Cronyn John Howard Leslie Chiang Lisa Le Zandraetta Tims-Cook Alida M Gertz Trichosporon asahii Urinary Tract Infection in a Patient with Severe COVID-19 Case Reports in Infectious Diseases |
| title | Trichosporon asahii Urinary Tract Infection in a Patient with Severe COVID-19 |
| title_full | Trichosporon asahii Urinary Tract Infection in a Patient with Severe COVID-19 |
| title_fullStr | Trichosporon asahii Urinary Tract Infection in a Patient with Severe COVID-19 |
| title_full_unstemmed | Trichosporon asahii Urinary Tract Infection in a Patient with Severe COVID-19 |
| title_short | Trichosporon asahii Urinary Tract Infection in a Patient with Severe COVID-19 |
| title_sort | trichosporon asahii urinary tract infection in a patient with severe covid 19 |
| url | http://dx.doi.org/10.1155/2021/6841393 |
| work_keys_str_mv | AT verschoylecronyn trichosporonasahiiurinarytractinfectioninapatientwithseverecovid19 AT johnhoward trichosporonasahiiurinarytractinfectioninapatientwithseverecovid19 AT lesliechiang trichosporonasahiiurinarytractinfectioninapatientwithseverecovid19 AT lisale trichosporonasahiiurinarytractinfectioninapatientwithseverecovid19 AT zandraettatimscook trichosporonasahiiurinarytractinfectioninapatientwithseverecovid19 AT alidamgertz trichosporonasahiiurinarytractinfectioninapatientwithseverecovid19 |